Medicare Enrolled

Dr. Holly Debuys, MD

Dermatology · Southlake, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3065 W SOUTHLAKE BLVD # 140, Southlake, TX 76092
8173805911
In practice since 2006 (19 years)
NPI: 1003833658 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Debuys from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Debuys? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Debuys

Dr. Holly Debuys is a dermatology specialist in Southlake, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Debuys performed 2,817 Medicare services across 1,569 unique beneficiaries.

Between the years covered by Open Payments, Dr. Debuys received a total of $4,578 from 36 pharmaceutical and/or device companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Debuys is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 42% volume in TX $4,578 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,817
Medicare services
Top 42% in TX for dermatology
1,569
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~148 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 907 $5 $53
Office visit, established patient (20-29 min) 473 $61 $215
Office visit, established patient (30-39 min) 430 $87 $291
Destruction of skin growths (warts/lesions), 1-14 298 $81 $314
Destruction of precancerous skin growth, 1 267 $37 $208
Skin biopsy, tangential 113 $66 $277
Destruction of skin growth, 15 or more growths 76 $98 $286
Office visit, established patient (10-19 min) 68 $38 $126
Destruction of precancer skin growth, 15 or more growths 31 $126 $564
New patient office visit (30-44 min) 26 $73 $238
Biopsy of related skin growth, each additional growth 25 $41 $159
New patient office visit (45-59 min) 25 $101 $365
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm 20 $115 $766
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less 18 $189 $535
Punch biopsy, first skin growth 17 $96 $442
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm 12 $69 $468
Biopsy of ear 11 $60 $533
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,578
Total received (2018-2024)
Avg $654/year across 7 years
Top 44% in TX for dermatology
36
Companies
197
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,490 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$88 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$848
2023
$191
2022
$625
2021
$678
2020
$231
2019
$1,106
2018
$899

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$643
ABBVIE INC.
$485
Almirall LLC
$441
AbbVie, Inc.
$401
Galderma Laboratories, L.P.
$338
VYNE Pharmaceuticals Inc.
$202
Celgene Corporation
$200
Incyte Corporation
$144
Allergan Inc.
$141
Encore Dermatology Inc.
$139
Novartis Pharmaceuticals Corporation
$133
LEO Pharma Inc.
$133
Amgen Inc.
$129
Medimetriks Pharmaceuticals, Inc.
$110
AbbVie Inc.
$105
Arcutis Biotherapeutics, Inc.
$90
Janssen Biotech, Inc.
$88
Exeltis, USA Inc.
$85
GENZYME CORPORATION
$67
Regeneron Healthcare Solutions, Inc.
$64
Ortho Dermatologics, a division of Bausch Health US, LLC
$60
Verrica Pharmaceuticals Inc.
$51
Lilly USA, LLC
$44
Pierre Fabre Pharmaceuticals, Inc.
$38
SUN PHARMACEUTICAL INDUSTRIES INC.
$33
Sun Pharmaceutical Industries Inc.
$28
Glenmark Therapeutics Inc.
$27
E.R. Squibb & Sons, L.L.C.
$24
DUSA Pharmaceuticals, Inc.
$22
UCB, Inc.
$19
Genentech USA, Inc.
$19
Aclaris Therapeutics, Inc.
$18
Sebela Pharmaceuticals Inc.
$16
Dermavant Sciences, Inc.
$15
Sensus Healthcare, Inc.
$15
STRATA Skin Sciences, Inc.
$12
Top 3 companies account for 34.3% of total payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMZEEQ · Absorica LD · BOTOX · BOTOX COSMETIC · BRYHALI · CIBINQO · COSENTYX · Cimzia · Clindacin Pac · Cordran · DUOBRII · DUPIXENT · Dermatological Psoriasis and Vitiligo Treatment · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Enbrel · Erivedge · HUMIRA · Humira · Impoyz · Klisyri · Mupirocin Cream · Nicadan · ODOMZO · OPZELURA · ORACEA · Otezla · PRAMOSONE · RHOFADE · RINVOQ · SKYRIZI · SOOLANTRA · Seysara · Skyrizi · Sotyktu · Synalar · TALTZ · TREMFYA · TRI-LUMA · TRILUMA · VTAMA · Veltin · Winlevi · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $163 per 100 Medicare services performed
Looking for a dermatology specialist in Southlake?
Compare dermatologists in the Southlake area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
213
Per 100K population
10.0
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHLAKE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Debuys is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Debuys experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Debuys performed 907 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Debuys receive payments from pharmaceutical companies?
Yes. Dr. Debuys received a total of $4,578 from 36 companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Debuys's costs compare to other dermatologists in Southlake?
Dr. Debuys's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Debuys) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →